US2024029853A1PendingUtilityA1

Managing Insulin Administration

Assignee: ASEKO INCPriority: Jun 7, 2016Filed: Jun 26, 2023Published: Jan 25, 2024
Est. expiryJun 7, 2036(~9.9 yrs left)· nominal 20-yr term from priority
G16H 20/17G16H 20/60G16Z 99/00G16H 40/63G16H 10/40
75
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method includes obtaining blood glucose measurements and blood glucose times of a patient from a blood glucose meter and executing a patient management program configured to display on a screen a graphical user interface having a trend window of the blood glucose measurements on the time line. The patient management program is configured to receive, in the trend window magnifying inputs for a magnification window superimposed on a segment of the timeline to specify a date range for a magnified window. The patient management program is further configured to display the magnified window including the blood glucose measurements of the patient from the specified date range and display a first information window including quantitative information associated with the blood glucose measurements from the specified date range.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A computer-implemented method executing on data processing hardware that causes the data processing hardware to perform operations comprising:
 obtaining glucose measurements of a patient and glucose times associated with a time of measuring each glucose measurement from a glucose sensor associated with the patient; and   executing a patient management program configured to display on a screen in communication with the data processing hardware a graphical user interface having a trend window of the blood glucose measurements on a timeline, wherein the patient management program is configured to:
 receive, in the graphical user interface, a user input indication from a medical professional to specify a date range; 
 display, in the graphical user interface, the trend window including the glucose measurements of the patient from the specified date range; and 
 display, in the graphical user interface, a first information graphic including quantitative information associated with an average number of times the patient checks the glucose measurements measured from the glucose sensor per day within the specified date range. 
   
     
     
         2 . The computer-implemented method of  claim 1 , wherein the operations further comprise:
 receiving insulin dosing parameters for the patient input by a healthcare provider; and   transmitting the insulin dosing parameters to a patient device associated with the patient.   
     
     
         3 . The computer-implemented method of  claim 2 , wherein the insulin dosing parameters for the patient comprise a carbohydrate-to-insulin ratio for the patient. 
     
     
         4 . The computer-implemented method of  claim 2 , wherein the insulin dosing parameters for the patient comprise a correction factor for the patient. 
     
     
         5 . The computer-implemented method of  claim 2 , wherein the insulin dosing parameters for the patient comprise a target glucose range for the patient. 
     
     
         6 . The computer-implemented method of  claim 1 , wherein the operations further comprise:
 receiving, from a patient device associated with the patient, a message directed toward a healthcare provider of the patient, the message comprising an inquiry related to insulin dosing parameters for the patient; and   displaying the message on the screen.   
     
     
         7 . The computer-implemented method of  claim 1 , wherein the operations further comprise determining, based on the glucose measurements of the patient from the specified date range, an estimated hemoglobin A1c value for the patient. 
     
     
         8 . The computer-implemented method of  claim 7 , wherein the operations further comprise displaying, in the graphical user interface, a second information graphic including quantitative information associated with the estimated hemoglobin A1c for the patient. 
     
     
         9 . The computer-implemented method of  claim 1 , wherein the operations further comprise determining, based on the glucose measurements of the patient from the specified date range, an average glucose measurement value for the specified date range. 
     
     
         10 . The computer-implemented method of  claim 9 , wherein the operations further comprise displaying, in the graphical user interface, a second information graphic including quantitative information associated with the average glucose measurement value for the specified date range. 
     
     
         11 . A system comprising:
 data processing hardware; and   memory hardware in communication with the data processing hardware, the memory hardware storing instructions that when executed on the data processing hardware cause the data processing hardware to perform operations comprising:   obtaining glucose measurements of a patient and glucose times associated with a time of measuring each glucose measurement from a glucose sensor associated with the patient; and   executing a patient management program configured to display on a screen in communication with the data processing hardware a graphical user interface having a trend window of the blood glucose measurements on a timeline, wherein the patient management program is configured to:   receive, in the graphical user interface, a user input indication from a medical professional to specify a date range;   display, in the graphical user interface, the trend window including the glucose measurements of the patient from the specified date range; and   display, in the graphical user interface, a first information graphic including quantitative information associated with an average number of times the patient checks the glucose measurements measured from the glucose sensor per day within the specified date range.   
     
     
         12 . The system of  claim 11 , wherein the operations further comprise:
 receiving insulin dosing parameters for the patient input by a healthcare provider; and   transmitting the insulin dosing parameters to a patient device associated with the patient.   
     
     
         13 . The system of  claim 12 , wherein the insulin dosing parameters for the patient comprise a carbohydrate-to-insulin ratio for the patient. 
     
     
         14 . The system of  claim 12 , wherein the insulin dosing parameters for the patient comprise a correction factor for the patient. 
     
     
         15 . The system of  claim 12 , wherein the insulin dosing parameters for the patient comprise a target glucose range for the patient. 
     
     
         16 . The system of  claim 11 , wherein the operations further comprise:
 receiving, from a patient device associated with the patient, a message directed toward a healthcare provider of the patient, the message comprising an inquiry related to insulin dosing parameters for the patient; and   displaying the message on the screen.   
     
     
         17 . The system of  claim 11 , wherein the operations further comprise determining, based on the glucose measurements of the patient from the specified date range, an estimated hemoglobin A1c value for the patient. 
     
     
         18 . The system of  claim 17 , wherein the operations further comprise displaying, in the graphical user interface, a second information graphic including quantitative information associated with the estimated hemoglobin A1c for the patient. 
     
     
         9 . The system of  claim 11 , wherein the operations further comprise determining, based on the glucose measurements of the patient from the specified date range, an average glucose measurement value for the specified date range. 
     
     
         20 . The system of  claim 11 , wherein the operations further comprise displaying, in the graphical user interface, a second information graphic including quantitative information associated with the average glucose measurement value for the specified date range.

Join the waitlist — get patent alerts

Track US2024029853A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.